Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia

Por Gandhi, Varsha, Plunkett, William, Cortes, Jorge E.
Publicado em 2014

Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?

Por Jabbour, Elias, Cortes, Jorge E., Kantarjian, Hagop M.
Publicado em 2009

Molecular Monitoring in Chronic Myeloid Leukemia: Response to Tyrosine Kinase Inhibitors and Prognostic Implications

Por Jabbour, Elias, Cortes, Jorge E., Kantarjian, Hagop M.
Publicado no Cancer (2008)

Diagnosis and Treatment of Chronic Myeloid Leukemia (CML) in 2015

Por Thompson, Philip A, Kantarjian, Hagop, Cortes, Jorge E
Publicado no Mayo Clin Proc (2015)

Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options

Por Jabbour, Elias J., Cortes, Jorge E., Kantarjian, Hagop M.
Publicado em 2013

Tyrosine kinase inhibition: A therapeutic target for the management of chronic-phase chronic myeloid leukemia

Por Jabbour, Elias J, Cortes, Jorge E, Kantarjian, Hagop M
Publicado em 2013

Early Cytogenetic and Molecular Response During First-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase: Long-Term Implications

Por Quintás-Cardama, Alfonso, Cortes, Jorgé E., Kantarjian, Hagop M.
Publicado em 2011

Measuring symptoms as a critical component of drug development and evaluation in hematological diseases

Por Williams, Loretta A, Yucel, Emre, Cortes, Jorge E, Cleeland, Charles S
Publicado em 2013

Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia

Por Chen, Lisa S., Redkar, Sanjeev, Taverna, Pietro, Cortes, Jorge E., Gandhi, Varsha
Publicado em 2011

Phase I/II study of low-dose azacytidine in patients with chronic myeloid leukemia who have minimal residual disease while receiving therapy with tyrosine kinase inhibitors

Por Maiti, Abhishek, Cortes, Jorge E., Brown, Yolanda D., Kantarjian, Hagop M.
Publicado no Leuk Lymphoma (2016)

Therapy of Core Binding Factor Acute Myeloid Leukemia: Incremental Improvements Toward Better Long-Term Results

Por Bhatt, Vijaya Raj, Kantarjian, Hagop, Cortes, Jorge E., Ravandi, Farhad, Borthakur, Gautam
Publicado em 2012

Protein Profiling Identifies mTOR Pathway Modulation and Cytostatic Effects of Pim Kinase Inhibitor, AZD1208, in Acute Myeloid Leukemia

Por Chen, Lisa S., Yang, Ji-Yeon, Liang, Han, Cortes, Jorge E., Gandhi, Varsha
Publicado no Leuk Lymphoma (2016)

Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis

Por PARIKH, SAMEER A., KANTARJIAN, HAGOP M., RICHIE, MARY ANN, CORTES, JORGE E., VERSTOVSEK, SRDAN
Publicado em 2010

Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia

Por Jabbour, Elias J., Hughes, Timothy P., Cortés, Jorge E., Kantarjian, Hagop M., Hochhaus, Andreas
Publicado em 2013

Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia

Por Jabbour, Elias, Branford, Susan, Saglio, Giuseppe, Jones, Dan, Cortes, Jorge E., Kantarjian, Hagop M.
Publicado em 2010

The impact of dasatinib on pregnancy outcomes

Por Cortes, Jorge E., Abruzzese, Elisabetta, Chelysheva, Ekaterina, Guha, Mausumee, Wallis, Nicola, Apperley, Jane F.
Publicado no Am J Hematol (2015)

Current Practices in the Management of Chronic Myeloid Leukemia

Por Kantarjian, Hagop M., Larson, Richard A., Cortes, Jorge E., Deering, Kathleen L., Mauro, Michael J.
Publicado em 2012

Dasatinib 100 mg Once Daily Minimizes the Occurrence of Pleural Effusion in Patients With Chronic Myeloid Leukemia in Chronic Phase and Efficacy Is Unaffected in Patients who Devel...

Por Porkka, Kimmo, Khoury, H. Jean, Paquette, Ronald L., Matloub, Yousif, Sinha, Ritwik, Cortes, Jorge E.
Publicado em 2010

Ocular Granulocytic Sarcoma: A Case Report and Literature Review of Ocular Extramedullary Acute Myeloid Leukemia

Por Ohanian, Maro, Borthakur, Gautam, Quintas-Cardama, Alfonso, Mathisen, Michael, Cortés, Jorge E., Estrov, Zeev, Pemmaraju, Naveen
Publicado em 2012

Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience

Por Masarova, Lucia, Cherry, Mohamad, Newberry, Kate J., Estrov, Zeev, Cortes, Jorge E., Kantarjian, Hagop M., Verstovsek, Srdan
Publicado no Leuk Lymphoma (2015)